APP and Alzheimer disease: Furthermore, the complexity of AD pathogenesis necessitates the development of multi-target compounds that might aid in preventing and/or reversing the progression of AD by countering the dilatant pathological mechanisms like aberrant APP processing, toxic tau conformations, neuroinflammation, etc.